Elevra Lithium Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing, dated November 4, 2025, covers the month of October 2025. It serves as an application for the quotation of securities on the Australian Securities Exchange (ASX) following a corporate transaction.
Key Financial Metrics and Capital Structure
The filing details a non-cash issuance of 582,770 ordinary fully paid shares (ASX code: ELV). The consideration for these shares was valued at AUD 3.90 per security. The issuance was not for cash but represented the settlement of vested Piedmont Equity Awards resulting from a Change in Control of Piedmont Lithium Inc. connected to a Merger.
Following this issuance, the company's capital structure is as follows:
- Quoted Ordinary Shares: 169,329,111
- Unquoted Performance Rights (ELVAM): 1,771,386
- Unquoted Options (Various): 17,635,230 (comprising 14,897 various options and 2,723,613 options expiring December 31, 2028)
The filing text does not provide data on revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change is the increase in issued ordinary share capital by 582,770 shares. This issuance completes a transaction previously announced on August 29, 2025, regarding the settlement of equity awards tied to the Piedmont Lithium Inc. merger.
Outlook and Risks
The filing contains no management commentary, financial guidance, or specific risk factors beyond the standard disclosure of the equity settlement. The transaction is described as a completed settlement of vested awards.
Investor Verification Checklist
- Verify the total number of ordinary shares on issue (169,329,111) against the company's latest capitalization table.
- Confirm the details of the Piedmont Lithium Inc. merger and the specific terms of the equity award settlement.
- Review the August 29, 2025, Appendix 3B announcement referenced in this filing for the original transaction terms.
- Check the status and vesting schedules of the unquoted performance rights and options listed in Part 4.2.